Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

Groundbreaking research suggests that Triple-Negative Breast Cancer is "addicted" to lipids, prompting experts to warn ...

ILC makes up 10–15% of all invasive breast cancers but often goes underdiagnosed due to its diffuse growth pattern. The hallmark of ILC is the loss of E-cadherin, leading to its characteristic ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...

International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party now the National Cancer Research Institute Bladder Cancer Clinical Studies Group, European ...

Enhertu significantly improves invasive disease-free survival in high-risk HER2-positive early breast cancer patients compared to Kadcyla post-neoadjuvant therapy. DESTINY-Breast05 trial results ...

When cancer returned last year, it did so in a very different chapter of her life. This time, a rare stage IV sarcoma complicated her breast cancer. She now faced a difficult decision regarding ...

Source: Getty Images The 2025 EAU guidelines provide updated insights into risk factors, diagnosis, classification, treatment, and follow-up of patients with muscle-invasive and metastatic bladder ...

Disclaimer: Trastuzumab deruxtecan has not been approved by the FDA for the neoadjuvant or adjuvant setting for early-stage, ...